Research map: Blood Pressure Status Modulates the Therapeutic Response to Sodium‐Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial

Back to the article

Papers in this map

  1. The Early Pathogenesis of Diabetic Retinopathy and Its Attenuation by Sodium–Glucose Transporter 2 Inhibitors · Mayumi Yamato · 2024 · 34 citations · Cited by this paper
  2. Ophthalmic Backgrounds Influencing the Efficacy of SGLT2 Inhibitor in Diabetic Macular Oedema: Post‐hoc Analysis of the COMET Trial · Ryoichi Ishibashi · 2026 · 2 citations · Cites this paper
  3. Beyond GLP ‐1 · 2026 · Related
  4. SGLT2 inhibitors as metabolic modulators: beyond glycemic control in type 2 diabetes · Qian Wu · 2025 · 18 citations · Cited by this paper
  5. Meta-analysis of sodium glucose transport 2 inhibitors versus other glucose-lowering agents on the progression of diabetic retinopathy and diabetic macular edema · Rukayat Olabisi Akande · 2026 · Cites this paper
  6. November 11–12, 2025, T1DX‐QI Learning Session, Journal of Diabetes · 2026 · Related
  7. Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial · Ryoichi Ishibashi · 2025 · 10 citations · Cited by this paper
  8. Baseline HDL Cholesterol and the Anti‐ VEGF Injection‐Sparing Effect of an SGLT2 Inhibitor in Diabetic Macular Oedema: A Post Hoc Analysis of the COMET Trial · Ryoichi Ishibashi · 2026 · Cites this paper
  9. Multimorbidity between Type 2 Diabetes and Depressive Symptoms in Mexico: Prevalence and Associated Factors From the Nationally Representative ENSANUT 2022 Survey · 2026 · Related
  10. Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial · Jelle M. Beernink · 2025 · 7 citations · Cited by this paper
  11. Sodium–Glucose Cotransporter 2 Inhibition in Diabetic Macular Oedema: Emerging Evidence for Stage‐Dependent Systemic‐Retinal Responsiveness · Ryoichi Ishibashi · 2026 · Cites this paper
  12. Effect of Topical Application of Antimicrobial Peptide PL ‐5 (Peceleganan) Spray on Mild to Moderate Infection of Diabetic Foot Ulcers: A Multicenter, Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial · 2026 · Related
  13. Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active‐Controlled Study · 2026 · Related
  14. Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression · 2026 · Related
  15. Diabetes and the Retina: The Role of Medical Treatment · 2025 · Related
  16. Mitochondrial Homeostasis in Pancreatic β Cell Function: Mechanisms and Therapeutic Targets for Diabetes · 2026 · Related
  17. Updates in Type 1 Diabetes ( T1D ): What Recent Findings Might Mean for Treatment and Prevention Strategies · 2026 · Related
  18. Impact of Imatinib Therapy on Immunometabolism to Promote β‐Cell Survival in Diabetes · 2026 · Related

Source: OpenAlex (CC0)